Evogene Schedules Fourth Quarter 2024 Financial Results Release
Zoom conference call scheduled for March 6, 2025, 9:00 AM ET Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025. http://mma.prnewswire.com/media/1947468/4576969/Evogene_Logo.jpg Later that day, Company […]